| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3263044 | Digestive and Liver Disease | 2013 | 8 Pages |
Abstract
Tight temporal and spatial control of transgene IL-2 expression can be achieved by a plasmid containing an RU486 inducible system driven by liver specific promoter. pRS-mIL-2 exhibited strong antitumour efficacy following consecutive induction with RU486.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Endocrinology, Diabetes and Metabolism
Authors
Wei Cheng, Lanfang Miao, Haiying Zhang, Ou Yang, He Ge, Yanru Li, Lin Wang,